Generic Ozempic is now available in Canada. After years of anticipation, the first two generic versions of semaglutide — the active ingredient in Ozempic — received Canadian authorization in April and May 2026. Apotex announced its Canadian commercial launch on May 14; stock depends on the pharmacy and product. Considering that an estimated three million Canadian adults are taking GLP-1 medications like Ozempic, this is a major development, especially for anyone paying out of pocket.
The two generics come from Dr. Reddy’s Laboratories and Apotex, whose version is sold as Apo-Semaglutide Injection. It’s worth clearing up one early point of confusion: these are genuine third-party generics, which is not the same thing as Plosbrio, a separate Novo Nordisk semaglutide brand authorized for type 2 diabetes. Its price and availability must be checked for the exact product.
In this article, we cover where generic Ozempic in Canada stands today, what it costs, how the switch from brand-name Ozempic works, and how semaglutide compares to other GLP-1 medications.
What Is Generic Ozempic?
Ozempic is the brand name for an injectable GLP-1 medication manufactured by Novo Nordisk. The active ingredient of Ozempic is a molecule called semaglutide. Generic Ozempic is that exact same molecule (semaglutide), manufactured by a different pharmaceutical company.
Semaglutide belongs to a class of medications called GLP-1 receptor agonists. It works by mimicking a natural gut hormone that triggers insulin release, slows down digestion, and usually reduces appetite. Officially, semaglutide is prescribed as a once-weekly injection for adults with Type 2 diabetes to help manage blood sugar. However, because it often produces weight loss in people who take it, doctors also prescribe semaglutide off-label for weight management.
To be approved by Health Canada, a generic drug must undergo rigorous testing to prove it is equivalent to the brand-name version. Health Canada concluded that the authorized generics meet its requirements for safety, effectiveness and quality against Ozempic. Other ingredients, devices and dosing instructions need not be identical; check the exact product with your pharmacist. Going forward, generic versions of the medication will probably just be referred to as semaglutide, rather than generic Ozempic.
See our Ultimate Guide to Semaglutide for more detailed information on the molecule, its side effects, and its clinical uses.
Is Generic Ozempic Available in Canada?
Yes. Generic Ozempic is now available in Canada and is rolling out to pharmacies across the country.
Health Canada approved the first generic version of semaglutide, from Dr. Reddy’s Laboratories, on April 28, 2026, making Canada the first G7 country to authorize a generic semaglutide. Three days later, on May 1, Apotex (Canada’s largest domestic drug manufacturer) became the second company to win approval. Apotex commercially launched its product — Apo-Semaglutide Injection — on May 14, and began shipping to pharmacies shortly after. Authorization dates are distinct from commercial launch and local pharmacy stock; ask which approved product is available for your prescription.
Apotex’s launch announcement lists 2 mg and 4 mg prefilled pens. These numbers describe total pen contents: the 2 mg pen delivers 0.25 mg or 0.5 mg doses, and the 4 mg pen delivers 1 mg doses. They are not instructions to inject the entire pen. Like branded Ozempic, they’re approved for one official use: a once-weekly injection for adults with Type 2 diabetes to help manage blood sugar. And just like the brand, doctors can also prescribe them off-label for weight management. Coverage for off-label use depends on the plan. Approval for type 2 diabetes does not automatically extend to weight management or guarantee reimbursement.
Health Canada is reviewing several more generic semaglutide submissions from other manufacturers, with further approvals expected in the coming months. You can see the current list on Health Canada’s generic submissions under review page.
Why Canada Got Generic Ozempic Early
Canada became the first G7 country to authorize a generic semaglutide on April 28, 2026. Patent and regulatory protections vary between countries, so Canadian authorization does not establish availability elsewhere.
Health Canada describes these generics as complex synthetic products that are pharmaceutically equivalent to the reference biologic drug. It reviewed evidence that product differences do not affect safety, effectiveness or quality.
How the Switch to Generic Semaglutide Works
Ask your pharmacist whether an approved generic can be dispensed on your existing prescription. Substitution and reimbursement requirements depend on provincial rules, the product, your prescription and your insurer; there is no single automatic rule that applies to every Canadian prescription.
Before switching, confirm the product name, prescribed weekly dose, pen strength, directions and final cost. The same active ingredient does not make every device interchangeable. Ask for a demonstration if the pen is unfamiliar.
Availability can vary by pharmacy and product. A Health Canada approval, manufacturer launch and a pharmacy having stock are separate milestones.
How Much Does Generic Ozempic Cost in Canada?
Generic semaglutide can reduce treatment costs, but the price of generic Ozempic in Canada is not one fixed monthly amount. Brand savings programs, the dose and the number of doses supplied can also change the comparison.
Ask for a quote for the exact product and days supplied, including dispensing fees and pharmacy markup. Then compare the final amount after insurance or eligible manufacturer savings. A reported launch price is not a guaranteed current pharmacy price.
How Generic Price Drops Work
In Canada, generic drug prices are governed by the pan-Canadian Pharmaceutical Alliance (pCPA), whose tiered pricing framework considers the reference-brand price and the number of manufacturers. These public-plan pricing rules do not by themselves establish your retail price or predict a future reduction for a specific product.
Note: these mechanics set the public drug plan price. What you actually pay at the counter also depends on your provincial coverage, your private insurance, and the dispensing fees and markups at your local pharmacy. For a current, accurate number, ask your pharmacist, as they can tell you what the generic costs and what your plan covers.
Has Brand-Name Ozempic Responded?
Yes. Novo Nordisk’s Canadian Ozempic savings program says eligible patients paying out of pocket or using private insurance can obtain a price aligned with generic alternatives. Exclusions apply: the Ozempic card is unavailable in Quebec and cannot be combined with publicly funded insurance. Patients may still have uncovered costs, and the program can change or stop.
Plosbrio is another Novo Nordisk semaglutide brand authorized for type 2 diabetes; it is distinct from the Apotex and Dr. Reddy’s generic products. Compare actual product availability and out-of-pocket quotes with your pharmacist.
What If I’m Paying Out of Pocket?
If generic semaglutide is prescribed off-label for weight loss, check whether your plan covers that prescribed use. A diabetes listing does not automatically cover weight management; you may have to pay out of pocket.
The good news is that the generic price drop still benefits you directly. Lower generic pricing may reduce the amount you pay, but fees, coverage and brand savings programs can affect the result. Compare the final cost for an equivalent prescribed supply.
How Does Generic Ozempic Compare to Other GLP-1 Medications?
Three GLP-1 medications dominate the Canadian market: Ozempic, Wegovy, and Mounjaro. The differences between them can be a little confusing, especially because two of them are semaglutide-based drugs. For the full landscape, see our GLP-1 Canada guide.
Ozempic vs. Wegovy (Both are Semaglutide)
Both Ozempic and Wegovy contain semaglutide. The practical differences include approved uses, dose schedules and available devices.
- Ozempic and its generics: The generic Ozempic products discussed here are authorized for adults with type 2 diabetes. The announced Apo-Semaglutide pens deliver doses up to 1 mg weekly; do not assume every generic pen supports every branded Ozempic dose.
- Wegovy: Wegovy has a chronic weight-management indication and a usual maintenance dose of 2.4 mg weekly after escalation. In STEP 1, adults without diabetes receiving semaglutide and lifestyle intervention lost 14.9% of body weight on average over 68 weeks. This was not a direct comparison with Ozempic or its generics.
Choose and compare treatments with your clinician; separate trials do not predict an individual’s extra weight loss or make products interchangeable.
Mounjaro & Zepbound (Branded Tirzepatide)
Mounjaro and Zepbound are brand names for a dual-agonist GLP-1 drug called tirzepatide. Just like the Ozempic and Wegovy split, Mounjaro is tirzepatide branded for diabetes, while Zepbound contains the same active ingredient with a weight-management indication; it is not distinguished from Mounjaro simply by a higher maximum dose.
In the SURMOUNT-1 study of adults without diabetes, tirzepatide produced average weight loss of 20.9% of body weight at the 15 mg dose after 72 weeks. This result is from a different trial and population than the semaglutide studies. Compare current product costs and suitability with your clinician and pharmacist.
Will There Be a Generic Wegovy or Rybelsus?
Wegovy and Rybelsus also contain semaglutide, but authorization of a generic Ozempic injection does not automatically establish a generic of another product.
- Generic Wegovy: Health Canada authorized Sevmia, an Apotex generic Wegovy injection, on June 29, 2026. Check the exact indication, dose, local availability and coverage.
- Rybelsus: This is an oral semaglutide tablet with formulation-specific administration requirements. An injectable generic cannot simply replace it. Ask your pharmacist to verify current authorization and availability for any proposed oral generic.
Will Generic Ozempic Be Covered by Public Drug Plans?
Public coverage depends on the exact product, prescribed use and provincial criteria. Health Canada approval is not a reimbursement decision.
For example, BC PharmaCare’s semaglutide Special Authority criteria concern type 2 diabetes after inadequate blood-sugar control on the maximum tolerated metformin dose. The page recommends considering at least a three-month metformin trial and lists coverage up to 1 mg weekly using the intended 1 mg-dose pen.
This diabetes criterion does not establish coverage for weight loss. Ask your pharmacist to check your product’s current benefit listing, authorization requirements, deductible and copayment.
Side Effects and Safety of Generic Semaglutide
Product safety notice: Health Canada lists a packaging recall for Dr. Reddy’s Semaglutide Injection labelled as 2 mg/pen, DIN 02567806, lot 7000544C, because the affected lot contains a 4 mg pen. Check your product and consult your pharmacist or healthcare provider about the notice before changing treatment. This notice concerns that specific product and lot.
Authorized generic semaglutide contains the same active ingredient as Ozempic and has been reviewed against the reference product. Read the safety information for your exact dispensed product; other ingredients and devices can differ.
The most common side effects are gastrointestinal, including nausea, vomiting, diarrhea, constipation, and fatigue. These tend to be most pronounced when you first start the medication or step up to a higher dose, and they typically ease as your body adjusts.
For a more detailed look at serious risks, dosing schedules, and what to expect when starting treatment, see our comprehensive Ozempic Canada guide.
For Apo-Semaglutide, review pregnancy and breastfeeding restrictions, thyroid-tumour history, other diabetes medicines and eye disease with your clinician. Seek urgent assessment for sudden loss of vision, severe persistent abdominal pain or a serious allergic reaction. Tell your procedure team about the medicine before anesthesia or sedation. Follow the patient information for your exact product.
Frequently Asked Questions About Generic Semaglutide
When Did Generic Ozempic Launch in Canada?
Generic Ozempic launched in Canada in May 2026. Apotex announced its Apo-Semaglutide Injection commercial launch on May 14. Dr. Reddy’s product was authorized on April 28. Authorization and launch dates do not establish stock at an individual pharmacy.
As with any new generic launch, availability rolls out gradually and can vary by region and pharmacy in the early going. If your pharmacy doesn’t have the generic in stock yet, it’s worth asking when they expect it — or checking with another pharmacy nearby.
Is Plosbrio the Same as Generic Ozempic?
Plosbrio is a Novo Nordisk semaglutide brand with Canadian authorization for type 2 diabetes. It is distinct from the Dr. Reddy’s and Apotex generic Ozempic products. Check the exact product, dose and current pharmacy availability before switching.
What is Apo-Semaglutide?
Apo-Semaglutide Injection is Apotex’s brand name for its generic version of Ozempic, launched in Canada in May 2026. Apotex is Canada’s largest domestic drug manufacturer. It contains semaglutide and is supplied in 2 mg and 4 mg prefilled pens. Those are total pen contents, not a single injection dose; follow the prescribed dose and device instructions.
Is generic Ozempic the same as compounded semaglutide?
No. An authorized generic is a specific product that Health Canada reviewed for safety, effectiveness and quality against its reference drug. A compounded preparation does not automatically have that regulatory status. Ask your pharmacist to identify the exact product and avoid treating an unapproved product as an authorized generic.
Will generic Ozempic look different from brand-name Ozempic?
The pens may look slightly different. Both Apotex and Dr. Reddy’s have designed pre-filled pens that closely match the dosing and use experience of branded Ozempic. But the packaging, labelling, and device design will not be identical to the Novo Nordisk product.
Will generic Ozempic be approved for weight loss in Canada?
The generic Ozempic products discussed here are authorized for type 2 diabetes. Sevmia is a separate generic Wegovy product authorized for chronic weight management. A switch requires review of the exact product, dose and indication.
Do I need a new prescription to get generic Ozempic?
Your pharmacist can tell you whether a generic can be dispensed on your existing prescription or whether clarification from the prescriber is needed. Requirements depend on provincial rules, the particular product and your prescription; automatic substitution is not a universal rule.
Will my private insurance cover generic Ozempic for weight loss?
It depends entirely on your specific plan. Just like public plans, many private insurers strictly limit semaglutide coverage to patients with Type 2 diabetes. However, if your private plan currently covers branded Ozempic for weight loss off-label, ask whether they require a generic or set reimbursement at a lower-cost alternative price.
Generic Ozempic Canada: The Bottom Line
The arrival of generic Ozempic in Canada is, above all, about access. For the millions of Canadians paying out of pocket — especially when a prescribed use is not covered by their plan — lower-cost choices may reduce a financial barrier. The actual savings depend on the product, pharmacy and coverage.
That said, weight management is a complex, highly individual process, and GLP-1 medications aren’t one-size-fits-all. Whether you’re wondering if generic semaglutide is right for you or weighing other options, it’s a decision worth making with a doctor who knows your history.
If you are in an eligible BC community, you can request an appointment with a licensed physician on the Walk In platform. Learn how to speak to a doctor online to discuss weight-management options. Appointment availability varies and any treatment depends on clinical assessment.
Speak With a Doctor Online About Weight Loss Treatment
Please note:
Walk In does not provide medical advice. The contents of this website, including text, graphics, images and any other material are intended for informational and educational purposes only and are not intended to substitute for professional medical advice, diagnosis or treatment. Although efforts are taken to keep any medical information on the website updated, we cannot guarantee that the information on our website is correct or reflects the most up-to-date medical information.
Please consult your physician for medical advice. Always seek the advice of a physician or other qualified healthcare provider with any questions regarding a medical condition. Never disregard or delay seeking professional medical advice or treatment because of something you have read on this website or on the internet.


